In memoriam: Clark Bublitz
Clark Bublitz, a metabolic enzymologist and a member of the American Society for Biochemistry and Molecular Biology since 1963, died Feb. 23. He was 94.

Born Dec. 8, 1927, in Merrill, Wisconsin, he was the son of Clark and Florence Bublitz. He attended the Pillsbury Military Academy in Owatonna, Minnesota, then joined the Army near the end of World War II and was stationed in Rome.
After the war, Bublitz earned a Ph.D. in biochemistry from the University of Chicago, and then he spent a year as a postdoctoral fellow at the Max Plank Institute in Germany where he worked with Feodor Lynen, who later shared the 1964 Nobel Prize in physiology or medicine.
Bublitz joined the faculty at the Johns Hopkins School of Medicine as an assistant professor. While at Hopkins, he met Deborah Keirstead, then a medical student. They were married in 1958. Bublitz spent a year at St. Louis University in Missouri before moving to the University of Colorado Medical Center in Denver, where he remained until his retirement.
Bublitz studied enzymes involved in metabolism in the rat liver, beginning in the 1950s with enzymes that phosphorylate glycerol. He later focused on L-gulonate, a six-carbon metabolite that is an important intermediate between glucose and the pentose phosphate pathway. In the 1960s, collaborating frequently with Albert Lehninger, he studied the conversion of gulonate into ascorbic acid, or vitamin C.
Bublitz was an enthusiastic hiker, tennis player and Green Bay Packers fan. He is survived by his wife, Deborah; five children, Nancy Dyer, Susan Schooleman, Philip Bublitz, Caroline Emsermann and Elizabeth Bublitz, and their spouses; and eight grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.